[go: up one dir, main page]

JPH0995452A - Fat-decomposing promoting agent - Google Patents

Fat-decomposing promoting agent

Info

Publication number
JPH0995452A
JPH0995452A JP7294329A JP29432995A JPH0995452A JP H0995452 A JPH0995452 A JP H0995452A JP 7294329 A JP7294329 A JP 7294329A JP 29432995 A JP29432995 A JP 29432995A JP H0995452 A JPH0995452 A JP H0995452A
Authority
JP
Japan
Prior art keywords
berberine
lipolysis
formula
extract
chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP7294329A
Other languages
Japanese (ja)
Inventor
Yoshihiro Ito
義博 伊藤
Hiromichi Okuda
拓道 奥田
Takashi Maoka
孝至 眞岡
Akihiko Matsumura
昭彦 松村
Koichiro Hino
宏一郎 日野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Institute for Production Development
Original Assignee
Research Institute for Production Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Institute for Production Development filed Critical Research Institute for Production Development
Priority to JP7294329A priority Critical patent/JPH0995452A/en
Publication of JPH0995452A publication Critical patent/JPH0995452A/en
Pending legal-status Critical Current

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain a lipid-decomposing promoting agent which contains a specific alkaloid as an active ingredient and is useful for medicines, cosmetics and health food products. SOLUTION: This alkaloid is included, as at least one active ingredient, in the Phellodendri Cortex extract and Coptidis Rhizoma extract, or is a berberine type alkaloid as at least one kind selected from the group consisting of a berberine salt of formula I (R<1> and R<2> are each a 1-5C alkyl; (n) is an integer of 1-5; X is a monovalent anion) or its derivative or a palmatine salt of formula II or its derivative and kopsidine salt of formula III or its derivative.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【発明の属する分野】本発明は、脂肪分解促進剤に関
し、さらに詳しくは、特定の植物から得られるエキスま
たは特定のアルカロイドを有効成分とする脂肪分解促進
剤に関する。本発明にかかる脂肪分解促進剤は、優れた
脂肪分解促進作用を有しており、医薬品、化粧品、健康
食品などの各分野に広く利用することができる。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a lipolysis promoter, and more particularly to a lipolysis promoter containing an extract obtained from a specific plant or a specific alkaloid as an active ingredient. The lipolysis-promoting agent according to the present invention has an excellent lipolysis-promoting action, and can be widely used in various fields such as pharmaceuticals, cosmetics, and health foods.

【0002】[0002]

【従来の技術】脂肪の蓄積過多は、種々の成人病の原因
となり、美容の面からも好ましいとはいえない。従来過
剰の脂肪を代謝分解するために、種々の植物や海藻から
の抽出物などが、化粧品などの形で用いられているが、
充分な効果をあげていないのが現状である。また、種々
の天然物から脂肪分解促進成分を抽出する試みもなされ
ているが、充分な成果をあげていない。
2. Description of the Related Art Excessive accumulation of fat causes various adult diseases and is not preferable in terms of beauty. Conventionally, in order to metabolically decompose excess fat, extracts from various plants and seaweed have been used in the form of cosmetics,
The current situation is that it is not sufficiently effective. Attempts have also been made to extract lipolysis-promoting components from various natural products, but the results have not been satisfactory.

【0003】[0003]

【発明が解決しようとする課題】医薬品、化粧品、食品
などの分野においては、安全性の高い天然由来の脂肪分
解促進剤に対する需要が増加している。ところが、現在
実用に供されている天然由来の脂肪分解促進剤の種類と
量は非常に限られている上、その使用に当たっても多岐
にわたる剤形、形態に処方しがたいという問題点があ
る。本発明は、上記問題点に鑑み、安全性が高い天然由
来の新規脂肪分解促進剤を大量且つ安定して供給しよう
とするものである。
In the fields of pharmaceuticals, cosmetics, foods, etc., there is an increasing demand for highly safe naturally-occurring lipolysis promoters. However, the type and amount of the naturally-derived lipolysis promoter currently in practical use are very limited, and it is difficult to formulate various dosage forms and forms even when used. In view of the above problems, the present invention intends to stably supply a large amount of a novel naturally-occurring lipolysis promoter with high safety.

【0004】[0004]

【課題を解決するための手段】本発明によれば、上記課
題は、黄柏エキスおよび黄連エキスからなる群から選択
される少なくとも1種の成分、またはベルベリン型アル
カロイドを有効成分として含んでなる脂肪分解促進剤に
より解決される。
According to the present invention, the above-mentioned problems can be solved by at least one component selected from the group consisting of Chinese cabbage extract and Orchid extract, or fat containing berberine-type alkaloid as an active ingredient. It is solved by a decomposition accelerator.

【0005】黄柏は、ミカン科のキハダPhellodendron
amurenseおよびその変種、またはPhellodendron chin
ense とその変種のコルク層を除いた樹皮を乾燥したも
ので、ベルベリン、パルマチン、ヤテオリジンなどのア
ルカロイドや、オオバクノン、オオバクラクトンなどの
苦味成分、リノール酸、β-シトステロールなどの脂質
を含み、苦味健医薬、整腸薬、消炎収斂薬として胃腸
炎、腹痛、黄疸、下痢などに、また打撲傷の湿布薬、目
薬など、漢方、民間薬として広く用いられている。しか
し、脂肪分解促進作用については、全く報告されておら
ず、また脂肪分解促進剤としての利用についても知られ
ていない。
Yellow crow is Phellodendron of Rutaceae.
amurense and its variants, or Phellodendron chin
It is a dried bark excluding the cork layer of ense and its varieties.It contains alkaloids such as berberine, palmatine, and yateolidine, bitterness components such as ovabacnon and obaclactone, and lipids such as linoleic acid and β-sitosterol. It is widely used as a health medicine, an intestinal remedy, and an antiphlogistic astringent for gastroenteritis, abdominal pain, jaundice, diarrhea, etc., and as a herbal medicine and folk medicine for bruising poultice and eye drops. However, the lipolysis promoting action has not been reported at all, and its use as a lipolysis promoting agent has not been known.

【0006】黄連は、キンポウゲ科のオウレンCoptis
japonicaまたはCoptis japonica var.dissectaの根茎
を乾燥したもので、ベルベリン、コプチジン、ヤテオリ
ジン、パルマチン、マグノフロリンなどのアルカロイド
やフエルラ酸を含み、苦味健胃薬、整腸薬として用いら
れている。また黄連解毒湯などとして漢方でも広く用い
られている。
Yellow lanterns are Coptis , a family of buttercups.
It is a dried rhizome of japonica or Coptis japonica var.dissecta. It contains alkaloids such as berberine, coptidine, yateolidine, palmatin and magnoflorin, and ferrulic acid, and is used as a bitter stomachic and intestinal medicine. It is also widely used in Chinese medicine as Orengedokuto.

【0007】黄柏または黄連からのエキスの抽出には、
溶媒として水、メタノール、エタノール、イソプロピル
アルコール、ブタノール、酢酸エチル、アセトン、エー
テル、クロロホルムなどを用いることができる。これら
の溶媒は2種以上を組み合わせて使用してもよい。これ
らのうち特に好ましい溶媒は、水、メタノール、エタノ
ールである。
To extract the extract from Huangba or Huanglian,
As the solvent, water, methanol, ethanol, isopropyl alcohol, butanol, ethyl acetate, acetone, ether, chloroform or the like can be used. You may use these solvents in combination of 2 or more types. Of these, particularly preferable solvents are water, methanol and ethanol.

【0008】ベルベリン型アルカロイドとしては、一般
式(I):
The berberine-type alkaloid has the general formula (I):

【0009】[0009]

【化4】 Embedded image

【0010】(式中、R1およびR2は、同一または異な
って、炭素数1〜5のアルキル基を表し、nは1〜5の
整数であり、Xは1価の陰イオンを表す。)で示される
ベルベリン塩またはその誘導体、一般式(II):
(In the formula, R 1 and R 2 are the same or different and each represents an alkyl group having 1 to 5 carbon atoms, n is an integer of 1 to 5, and X represents a monovalent anion. ), A berberine salt or a derivative thereof represented by the general formula (II):

【0011】[0011]

【化5】 Embedded image

【0012】(式中、R1、R2、R3およびR4は、同一
または異なって、炭素数1〜5のアルキル基を表し、X
は1価の陰イオンを表す。)で示されるパルマチン塩ま
たはその誘導体、および一般式(III)
(In the formula, R 1 , R 2 , R 3 and R 4 are the same or different and each represents an alkyl group having 1 to 5 carbon atoms;
Represents a monovalent anion. ) The palmat salt or its derivative represented by the general formula (III)

【0013】[0013]

【化6】 [Chemical 6]

【0014】(式中、nおよびmはそれぞれ1〜5の整
数であり、Xは1価の陰イオンを表す。)で示されるコ
プチジン塩またはその誘導体が好ましい。
(Wherein, n and m are each an integer of 1 to 5 and X represents a monovalent anion), and a coptidine salt or a derivative thereof is preferable.

【0015】R1およびR2が共にメチル基であり、nが
1であり、Xが塩素イオンである一般式(I)で示され
る塩化ベルベリン、またはR1〜R4がすべてメチル基で
あり、Xが塩素イオンである一般式(II)で示される塩
化パルマチンは、ミカン科のキハダPhellodendron amu
renseおよびその変種、またはPhellodendron chinense
およびその変種のコルク層を除いた樹皮、メギ科のメギ
Berberis thunbergiiの木部、ツツラフジ科のコロンボ
Jateorhiza columbaの根になどに含まれ、大腸菌、コ
レラ菌、チフス菌などグラム陰性菌に強い抗菌作用を示
し、健胃、整腸、殺菌剤として、細菌性の下痢、腸内異
常発酵などに、また打撲傷の湿布薬、目薬などに用いら
れる。
Berberine chloride represented by the general formula (I) in which R 1 and R 2 are both methyl groups, n is 1 and X is a chlorine ion, or R 1 to R 4 are all methyl groups chloride palmatine which X is represented by the general formula (II) is chlorine ion, the Rutaceae Phellodendron Phellodendron amu
rense and its variants, or Phellodendron chinense
And bark of its varieties excluding cork layer, barberry of barberry family
Berberis thunbergii xylem, Columbo of the family Aceraceae
It is contained in the roots of Jateorhiza columba and has a strong antibacterial action against gram-negative bacteria such as Escherichia coli, cholera, typhoid, and as a stomachic agent, intestinal rectifier, as a bactericidal agent, for bacterial diarrhea, abnormal intestinal fermentation, etc. It is also used for poultice and eye drops for bruising.

【0016】nおよびmが共に1であり、Xが塩素イオ
ンである一般式(III)で示される塩化コプチジンは、
キンポウゲ科のオウレンCoptis japonicaまたはCopti
s japonica var. dissectaの根茎に含まれ、苦味健医
薬、整腸薬、消炎収斂薬として胃腸炎、腹痛、黄疸、下
痢などに、また打撲傷の湿布薬、目薬などに用いられて
いる。しかし、塩化ベルベリン、塩化パルマチンおよび
塩化コプチジンのいずれについても、脂肪分解促進作用
は全く報告されておらず、また脂肪分解促進剤としての
利用についても知られていない。
Coptidine chloride represented by the general formula (III) in which n and m are both 1 and X is a chloride ion,
Coptis japonica or Copti of the buttercup family
It is contained in the rhizome of s japonica var. dissecta and is used for gastroenteritis, abdominal pain, jaundice, diarrhea, etc. as a bitter tasting medicine, antiflatulent, antiphlogistic astringent, and for poultice and eye drops for bruising. However, none of berberine chloride, palmatine chloride, and coptidine chloride has been reported to have a lipolysis-promoting action, and its use as a lipolysis-promoting agent has not been known.

【0017】ベルベリン塩またはその誘導体、パルマチ
ン塩またはその誘導体、およびコプチジン塩またはその
誘導体は、それぞれ単独で用いても、またはいずれか2
種以上をを組み合わせて用いてもよい。
The berberine salt or its derivative, the palmatine salt or its derivative, and the coptidine salt or its derivative may be used alone or in any two of them.
You may use it in combination of 2 or more types.

【0018】これらのベルベリン型アルカノイドとして
は、上記植物より抽出精製したもの、合成品、さらにオ
ウレンのカルス培養体より抽出精製したものなどが使え
る。さらに塩化ベルベリン、塩化パルマチン、または塩
化コプチジンを含有するキハダ、コロンボ根、メギ、オ
ウレンなどの抽出エキス、またはこれらのエキスを分画
したものなどを用いることもできる。
As these berberine-type alkanoids, those extracted and purified from the above-mentioned plants, synthetic products, and those extracted and purified from callus cultures of Coptis chinensis and the like can be used. Furthermore, it is also possible to use berberine chloride, palmatine chloride, or coptidine chloride-containing extracts such as yellowfin, colombo root, barberry, oren, or fractionated products of these extracts.

【0019】ベルベリン型アルカノイドの抽出には、溶
媒として水、メタノール、エタノール、イソプロピルア
ルコール、ブタノール、酢酸エチル、アセトン、エーテ
ル、クロロホルムなどを用いることができる。これらの
溶媒は2種以上を組み合わせて使用してもよい。これら
のうち特に好ましい溶媒は、水、メタノール、エタノー
ルである。また、これらのベルベリン型アルカノイドを
海藻エキスなど他の製剤に加えることもできる。
Water, methanol, ethanol, isopropyl alcohol, butanol, ethyl acetate, acetone, ether, chloroform and the like can be used as a solvent for the extraction of berberine-type alkanoid. You may use these solvents in combination of 2 or more types. Of these, particularly preferable solvents are water, methanol and ethanol. Further, these berberine-type arkanoids can be added to other preparations such as seaweed extract.

【0020】[0020]

【実施例】以下、実施例を示し、本発明の脂肪分解促進
剤の作用を具体的に説明する。
[Examples] The following will specifically describe the action of the lipolysis-promoting agent of the present invention by showing Examples.

【0021】実施例1 黄柏エキスの調製 黄柏1000gを、水3000mlにより90〜95℃、
1時間加熱抽出し、抽出液を濾過後、減圧濃縮してエキ
ス300gを得た。
Example 1 Preparation of yellow oak extract 1000 g of yellow oak was added to 3000 ml of water at 90 to 95 ° C.
After heat extraction for 1 hour, the extract was filtered and then concentrated under reduced pressure to obtain 300 g of the extract.

【0022】脂肪分解促進効果の測定 M. Rodbellらの方法(M. Rodbell et. al., J. B
iol. Chem. 239, 375-380 (1964)) により、Wistar系
オスのラットの副睾丸脂肪組織より調製した脂肪細胞5
0μlを、2.5%ウシ血清アルブミンのハンクス緩衝溶
液200μlと表1に示すサンプル25μlの混合溶液に
加えた。この混合液にノルエピネフリン溶液(0.5μg
/ml)25μlを加え、37℃で1時間インキュベート
した。反応液にクロロホルム:ヘプタン:メタノール
(98:98:4)3mlを加え、10分間撹拌振盪
し、脂質を抽出した。2500rpmで5分間遠心分離
し、銅試薬1mlを加え10分間振盪したのち2500rp
mで10分間遠心分離した後、上清0.5mlをとり、発色
試薬(バソクプロイン0.2g、ブチルヒドロキシアニソ
ール0.1gをクロロホルム200mlに溶解し調製)0.
5mlを加え、よく混ぜ、480nmの吸光度を測定して遊
離脂肪酸の量を測定した。これらの結果を表1に示す。
Measurement of lipolysis promoting effect M. Rodbell et al. (M. Rodbell et. Al., J. B.
iol. Chem. 239 , 375-380 (1964)), the adipocytes prepared from the epididymal adipose tissue of Wistar male rat 5
0 μl was added to a mixed solution of 200 μl of Hank's buffer solution of 2.5% bovine serum albumin and 25 μl of the sample shown in Table 1. Norepinephrine solution (0.5 μg
/ Ml) was added and the mixture was incubated at 37 ° C for 1 hour. Chloroform: heptane: methanol (98: 98: 4) (3 ml) was added to the reaction solution, and the mixture was stirred and shaken for 10 minutes to extract a lipid. Centrifuge at 2500 rpm for 5 minutes, add 1 ml of copper reagent and shake for 10 minutes, then 2500 rp
After centrifuging at m for 10 minutes, 0.5 ml of the supernatant was taken, and a coloring reagent (prepared by dissolving 0.2 g of bathocuproine and 0.1 g of butylhydroxyanisole in 200 ml of chloroform).
5 ml was added and mixed well, and the absorbance at 480 nm was measured to measure the amount of free fatty acid. Table 1 shows the results.

【0023】[0023]

【表1】 [Table 1]

【0024】黄柏水抽出エキスは、脂肪細胞に含まれる
トリグリセライドの脂肪酸を濃度依存的に遊離させた。
さらに生体内で脂肪分解にかかわるノルエピネフリンの
脂肪分解を増強する刮目すべき作用が認めらた。これら
の結果から黄柏には強い脂肪分解促進作用がある事が明
らかになつた。
The Huangqiao water extract extracted the fatty acids of triglyceride contained in adipocytes in a concentration-dependent manner.
Furthermore, a remarkable effect of enhancing the lipolysis of norepinephrine, which is involved in lipolysis in vivo, was observed. From these results, it was revealed that yellow oak has a strong lipolysis promoting action.

【0025】実施例2 塩化ベルベリン、塩化パルマチンまたは塩化コプチジン
のサンプル溶液(2.5%ウシ血清アルブミンのハンク
ス緩衝溶液)250μlにwistar系のオスのラットの副
睾丸脂肪組織より調製した脂肪細胞50μlを加え、3
7℃で1時間インキュベートした。この反応液にクロロ
ホルム:ペンタン:メタノール(98:98:4)3ml
を加え、10分間撹拌振盪し脂質を抽出した。2500
rpmで10分間遠心分離し、上層(水層)を吸引除去し
た後、銅試薬1mlを加え10分間振盪し2500rpmで
10分間遠心分離した後、上層0.5mlを別の試験管に
入れ、発色試薬0.5mlを加えてよく混ぜ、480nmの
吸光度を測定し遊離脂肪酸の量を測定した。それぞれの
結果を図1〜図3に示す。いずれも濃度依存的に脂肪細
胞に含まれるトリグリセライドの脂肪酸を遊離させた。
すなわち、塩化ベルベリンは、10-3moleで高い脂肪分
解能を示し、塩化パルマチンは、10-5moleで脂肪分解
を起こし、10-3moleで明かな脂肪分解を起こした。塩
化コプチジンは、10-5moleで脂肪分解を起こし、濃度
に依存して脂肪分解能が高くなるという刮目すべき作用
が認めらた。これらの結果から塩化ベルベリン、塩化パ
ルマチン、塩化コプチジンは強い脂肪分解促進作用を有
する事が明らかになつた。
Example 2 250 μl of a sample solution of berberine chloride, palmatine chloride or coptidine chloride (2.5% bovine serum albumin Hanks buffer solution) was mixed with 50 μl of adipocytes prepared from epididymal adipose tissue of wistar male rat. Plus 3
Incubated at 7 ° C for 1 hour. 3 ml of chloroform: pentane: methanol (98: 98: 4) was added to the reaction solution.
Was added and the mixture was stirred and shaken for 10 minutes to extract lipid. 2500
Centrifuge at rpm for 10 minutes, remove the upper layer (aqueous layer) by suction, add 1 ml of copper reagent, shake for 10 minutes, centrifuge at 2500 rpm for 10 minutes, then add 0.5 ml of the upper layer to another test tube to develop color. 0.5 ml of the reagent was added and mixed well, and the absorbance at 480 nm was measured to measure the amount of free fatty acid. The respective results are shown in FIGS. All of them released the fatty acid of triglyceride contained in adipocytes in a concentration-dependent manner.
That is, berberine chloride, it showed high fat resolution 10 -3 mole, palmatine chloride, cause lipolysis in 10 -5 mole, caused lipolysis apparent at 10 -3 mole. It was confirmed that coptidine chloride causes a lipolysis at 10 -5 mole and that the lipolytic ability is increased depending on the concentration, which is a remarkable effect. From these results, it was clarified that berberine chloride, palmatine chloride and coptidine chloride have strong lipolysis promoting action.

【0026】上記の通り、黄柏エキス、ならびに塩化ベ
ルベリン、塩化パルマチンおよび塩化コプチジンは、い
ずれも脂肪分解促進作用を有しており、肥満の防止に医
薬品、健康食品の分野で、また痩身効果から化粧品に広
く利用することができる。なおこれらの化合物は古くか
らまざまな内用薬、外用薬に用いられており、すでにそ
の安全性は認められている。
As mentioned above, the yellow oak extract, berberine chloride, palmatine chloride and coptidine chloride all have a lipolysis promoting action, and are used in the fields of medicines and health foods for the prevention of obesity, and for slimming effects in cosmetics. Can be widely used in. These compounds have been used for various internal and external medicines since ancient times, and their safety has already been confirmed.

【0027】[0027]

【発明の効果】本発明によれば、安全性の高い、天然由
来の優れた新規脂肪分解促進剤を提供できる。本脂肪分
解促進剤は医薬品、化粧品、健康食品などの各分野に応
じ、多岐にわたる利用が可能となる。
EFFECTS OF THE INVENTION According to the present invention, it is possible to provide a highly safe and novel naturally-occurring lipolysis promoter. The lipolysis promoter can be used in a wide variety of fields depending on fields such as pharmaceuticals, cosmetics, and health foods.

【図面の簡単な説明】[Brief description of drawings]

【図1】 実施例2における塩化パルマチンによる脂肪
酸分解の結果を示すグラフ。
FIG. 1 is a graph showing the result of fatty acid decomposition by palmatine chloride in Example 2.

【図2】 実施例2における塩化ベルベリンによる脂肪
酸分解の結果を示すグラフ。
FIG. 2 is a graph showing the result of fatty acid decomposition by berberine chloride in Example 2.

【図3】 実施例2における塩化コプシチンによる脂肪
酸分解の結果を示すグラフ。
FIG. 3 is a graph showing the result of fatty acid decomposition by copsicitin chloride in Example 2.

───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 7/00 A61K 7/00 K D (72)発明者 日野 宏一郎 長野県木曽郡木祖村藪原888─────────────────────────────────────────────────── ─── Continuation of the front page (51) Int.Cl. 6 Identification number Internal reference number FI Technical display location A61K 7/00 A61K 7/00 KD (72) Inventor Koichiro Hino 888 Yabuhara Kisomura, Kiso-gun, Nagano Prefecture

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】 黄柏エキスおよび黄連エキスからなる群
から選択される少なくとも1種の成分を有効成分として
含んでなる脂肪分解促進剤。
1. A lipolysis promoter comprising, as an active ingredient, at least one component selected from the group consisting of Chinese cabbage extract and Orchid extract.
【請求項2】 ベルベリン型アルカロイドを有効成分と
して含んでなる脂肪分解促進剤。
2. A lipolysis promoter comprising a berberine-type alkaloid as an active ingredient.
【請求項3】 ベルベリン型アルカロイドが、一般式
(I): 【化1】 (式中、R1およびR2は、同一または異なって、炭素数
1〜5のアルキル基を表し、nは1〜5の整数であり、
Xは1価の陰イオンを表す。)で示されるベルベリン塩
またはその誘導体、一般式(II): 【化2】 (式中、R1、R2、R3およびR4は、同一または異なっ
て、炭素数1〜5のアルキル基を表し、Xは1価の陰イ
オンを表す。)で示されるパルマチン塩またはその誘導
体、および一般式(III) 【化3】 (式中、nおよびmはそれぞれ1〜5の整数であり、X
は1価の陰イオンを表す。)で示されるコプチジン塩ま
たはその誘導体から成る群から選択される少なくとも1
種の化合物である請求項2に記載の脂肪分解促進剤。
3. A berberine-type alkaloid has the general formula (I): (In the formula, R 1 and R 2 are the same or different and represent an alkyl group having 1 to 5 carbon atoms, n is an integer of 1 to 5,
X represents a monovalent anion. ), A berberine salt or a derivative thereof, represented by the general formula (II): (In the formula, R 1 , R 2 , R 3 and R 4 are the same or different and each represents an alkyl group having 1 to 5 carbon atoms, and X represents a monovalent anion). Derivatives thereof, and general formula (III) (In the formula, n and m are each an integer of 1 to 5, and X
Represents a monovalent anion. ) At least one selected from the group consisting of coptidin salts represented by
The lipolysis-promoting agent according to claim 2, which is a kind of compound.
JP7294329A 1995-07-21 1995-11-13 Fat-decomposing promoting agent Pending JPH0995452A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7294329A JPH0995452A (en) 1995-07-21 1995-11-13 Fat-decomposing promoting agent

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP7-216469 1995-07-21
JP21646995 1995-07-21
JP7294329A JPH0995452A (en) 1995-07-21 1995-11-13 Fat-decomposing promoting agent

Publications (1)

Publication Number Publication Date
JPH0995452A true JPH0995452A (en) 1997-04-08

Family

ID=26521448

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7294329A Pending JPH0995452A (en) 1995-07-21 1995-11-13 Fat-decomposing promoting agent

Country Status (1)

Country Link
JP (1) JPH0995452A (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11269079A (en) * 1998-03-17 1999-10-05 Shiseido Co Ltd Preparation for external use for skin for promoting lipid degradation
JP2000063260A (en) * 1998-08-20 2000-02-29 Shiseido Co Ltd Lipid decomposition accelerator and skin preparation for external use for weight reduction
KR20030083348A (en) * 2002-04-22 2003-10-30 주식회사 엠디바이오알파 Obesity prevention and cure containing berberine having inhibitory effects on adipocyte differentiation (3T3-L1 and F442A cell)
JP2005239659A (en) * 2004-02-27 2005-09-08 Nicca Chemical Co Ltd Precursor lipocyte differentiation inhibitor
JP2006131578A (en) * 2004-11-09 2006-05-25 Matsuura Yakugyo Kk Extract obtained from lotus plant, method for producing the extract and anti-obesity agent
JP2007060905A (en) * 2005-08-29 2007-03-15 Daicho Kikaku:Kk Health food
JP2007314438A (en) * 2006-05-24 2007-12-06 Daicho Kikaku:Kk Antiobestic medicine
JP2008024620A (en) * 2006-07-20 2008-02-07 Nicca Chemical Co Ltd Adiponectin production inhibitor, skin care preparation, bath preparation, food and drink, and fodder
WO2008040192A1 (en) * 2006-09-30 2008-04-10 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences 13,13a-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE
JP2008513382A (en) * 2004-09-17 2008-05-01 インスティチュート オブ メディシナル バイオテクノロジー、 チャイニーズ アカデミー オブ メディカル サイエンシズ Methods and compositions for treating hyperlipidemia
JP2008231429A (en) * 2008-04-07 2008-10-02 Kanebo Cosmetics Inc Antioxidants and external preparations for skin
JP2009525990A (en) * 2006-02-09 2009-07-16 ナショナル・リサーチ・カウンシル・オブ・カナダ Pharmaceutical composition
WO2009151300A3 (en) * 2008-06-13 2010-02-04 Ahn-Gook Pharmaceutical Co., Ltd. Extract of coptidis rhizoma and use thereof in treating respiratory disease
CN100999522B (en) 2006-01-09 2010-09-01 金伟平 Preparation process of palmatine
JP2011519368A (en) * 2008-05-01 2011-07-07 アフェクサ ライフ サイエンシーズ インコーポレイテッド Pharmaceutical composition comprising an extract of yellow ream and bitter tea useful for reducing blood lipid concentration
JP2017048220A (en) * 2011-10-18 2017-03-09 株式会社アモーレパシフィックAmorepacific Corporation Sirt-1 activator including syringaresinol
JP2019512229A (en) * 2016-03-07 2019-05-16 ネイチャーズ サンシャイン プロダクツ、インク. Methods and compositions for further improving the health of diet and exercise weight loss and cardiovascular metabolism
CN116554163A (en) * 2023-05-17 2023-08-08 哈尔滨医科大学 2, 3-ethylenedioxy-9-substituted-10-methoxy dibenzoquinolizine derivative and pharmaceutical composition and application thereof

Cited By (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11269079A (en) * 1998-03-17 1999-10-05 Shiseido Co Ltd Preparation for external use for skin for promoting lipid degradation
JP2000063260A (en) * 1998-08-20 2000-02-29 Shiseido Co Ltd Lipid decomposition accelerator and skin preparation for external use for weight reduction
KR20030083348A (en) * 2002-04-22 2003-10-30 주식회사 엠디바이오알파 Obesity prevention and cure containing berberine having inhibitory effects on adipocyte differentiation (3T3-L1 and F442A cell)
JP2005239659A (en) * 2004-02-27 2005-09-08 Nicca Chemical Co Ltd Precursor lipocyte differentiation inhibitor
JP2008513382A (en) * 2004-09-17 2008-05-01 インスティチュート オブ メディシナル バイオテクノロジー、 チャイニーズ アカデミー オブ メディカル サイエンシズ Methods and compositions for treating hyperlipidemia
JP2006131578A (en) * 2004-11-09 2006-05-25 Matsuura Yakugyo Kk Extract obtained from lotus plant, method for producing the extract and anti-obesity agent
JP2007060905A (en) * 2005-08-29 2007-03-15 Daicho Kikaku:Kk Health food
CN100999522B (en) 2006-01-09 2010-09-01 金伟平 Preparation process of palmatine
JP2009525990A (en) * 2006-02-09 2009-07-16 ナショナル・リサーチ・カウンシル・オブ・カナダ Pharmaceutical composition
US8895079B2 (en) 2006-02-09 2014-11-25 National Research Council Of Canada Combinations of botanical extracts for promoting cardiovascular health
JP2007314438A (en) * 2006-05-24 2007-12-06 Daicho Kikaku:Kk Antiobestic medicine
JP2008024620A (en) * 2006-07-20 2008-02-07 Nicca Chemical Co Ltd Adiponectin production inhibitor, skin care preparation, bath preparation, food and drink, and fodder
WO2008040192A1 (en) * 2006-09-30 2008-04-10 Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences 13,13a-DIHYDROBERBERINE DERIVATIVES, THEIR PHARMACEUTICAL COMPOSITION AND USE
JP2008231429A (en) * 2008-04-07 2008-10-02 Kanebo Cosmetics Inc Antioxidants and external preparations for skin
JP2011519368A (en) * 2008-05-01 2011-07-07 アフェクサ ライフ サイエンシーズ インコーポレイテッド Pharmaceutical composition comprising an extract of yellow ream and bitter tea useful for reducing blood lipid concentration
US8425953B2 (en) 2008-06-13 2013-04-23 Ahn-Gook Pharmaceutical Co., Ltd. Extract of Coptidis rhizoma and novel use thereof in treating respiratory disease
WO2009151300A3 (en) * 2008-06-13 2010-02-04 Ahn-Gook Pharmaceutical Co., Ltd. Extract of coptidis rhizoma and use thereof in treating respiratory disease
USRE45524E1 (en) 2008-06-13 2015-05-19 Ahngook Pharmaceutical Co., Ltd. Extract of Coptidis rhizoma and novel use thereof in treating respiratory disease
JP2017048220A (en) * 2011-10-18 2017-03-09 株式会社アモーレパシフィックAmorepacific Corporation Sirt-1 activator including syringaresinol
US11096921B2 (en) 2011-10-18 2021-08-24 Amorepacific Corporation SIRT 1 activator including syringaresinol
JP2019512229A (en) * 2016-03-07 2019-05-16 ネイチャーズ サンシャイン プロダクツ、インク. Methods and compositions for further improving the health of diet and exercise weight loss and cardiovascular metabolism
US11122832B2 (en) 2016-03-07 2021-09-21 Nature's Sunshine Products, Inc. Methods and compositions to improve weight loss and cardiometabolic health beyond diet and excercise
CN116554163A (en) * 2023-05-17 2023-08-08 哈尔滨医科大学 2, 3-ethylenedioxy-9-substituted-10-methoxy dibenzoquinolizine derivative and pharmaceutical composition and application thereof

Similar Documents

Publication Publication Date Title
JPH0995452A (en) Fat-decomposing promoting agent
AU765951B2 (en) Pharmaceutical compositions and method of using same
US6210680B1 (en) Method for the prevention and treatment of chronic venous insufficiency
JP2002179586A (en) Lipase inhibitor
US20090131364A1 (en) Bioactive fraction from zingier officinale and a process for the preparation thereof
KR101626437B1 (en) Cosmetic composition for improving skin inflammation or reducing skin irritation
JP2003192605A (en) Lipase inhibitor
US6455070B1 (en) Composition for treating symptoms of influenza
WO2014119875A1 (en) Pharmaceutical composition for cough relief or discharge of phlegm, containing hot water extract of dendropanax morbiferus h.lev. leaves
US20080138384A1 (en) Oral hair growth stimulants comprising orthosiphon
CN103860611A (en) Crape myrtle extract as well as extraction method and application thereof
KR100476731B1 (en) A manufactoring process of depilatory made a affected part sprayer and a pill
CN1706264A (en) Coptidis or/and leaf tea
JP3549997B2 (en) Food composition and pharmaceutical composition having lipase inhibitory effect
KR101086811B1 (en) Natural extracts and compositions thereof having anti-influenza virus effects
KR100295389B1 (en) Antiviral pharmaceutical composition useful for prevention and treatment of a cold caused by influenza a virus and a functional food
KR101821925B1 (en) A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis
CN104770534A (en) Herb tea for reducing blood pressure and blood fat and preparation method thereof
JPH07252161A (en) Active oxygen eliminating agent and composition containing the agent
US4489067A (en) Lipid reducing agents
KR101738206B1 (en) A composition comprising the complex extract of Poncirus trifoliata and Cinnamommum cassia for treating or preventing allergy desmatitis
US7074436B2 (en) Method for the production of phyllanthus extracts
KR20220040421A (en) Cleansing composition for pet using Acorus calamus extract
WO2016122262A1 (en) Method for preparing licorice extract, and composition for preventing or treating oral diseases comprising extract obtained therefrom
CN112386630A (en) Brain-strengthening and intelligence-improving composition and preparation method and medical application thereof

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060110

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20060502